TY - JOUR T1 - The promising potential of piperlongumine as an emerging therapeutics for cancer A1 - Parama, Dey A1 - Rana, Varsha A1 - Girisa, Sosmitha A1 - Verma, Elika A1 - Daimary, Uzini Devi A1 - Thakur, Krishan Kumar A1 - Kumar, Aviral A1 - Kunnumakkara, Ajaikumar B Y1 - 2021/// KW - Piperlongumine KW - piplartine KW - Piper longum Linn. KW - cancer KW - signaling pathways KW - chemotherapy KW - radiotherapy KW - toxicity JF - Exploration of Targeted Anti-tumor Therapy VL - 2 SP - 323 EP - 354 DO - 10.37349/etat.2021.00049 UR - https://www.explorationpub.com/Journals/etat/Article/100249 N2 - In spite of the immense advancement in the diagnostic and treatment modalities, cancer continues to be one of the leading causes of mortality across the globe, responsible for the death of around 10 million patients every year. The foremost challenges faced in the treatment of this disease are chemoresistance, adverse effects of the drugs, and the high cost of treatment. Though scientific studies over the past few decades have foreseen and are focusing on the cancer-preventive and therapeutic potential of natural products and their underlying mechanism of action, many more of these agents are not still explored. Piperlongumine (PL), or piplartine, is one such alkaloid isolated from Piper longum Linn., which is shown to be safe and has significant potential in the prevention and therapy of cancer. Numerous shreds of evidence have established the ability of this alkaloid and its analogs and nanoformulations in modulating various complex molecular pathways such as phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin, nuclear factor-kappa B, Janus kinases/signal transducer and activator of transcription 3, etc. and inhibit different hallmarks of cancer such as cell survival, proliferation, invasion, angiogenesis, epithelial-mesenchymal-transition, metastases, etc. In addition, PL was also shown to inhibit radioresistance and chemoresistance and sensitize the cancer cells to the standard chemotherapeutic agents. Therefore, this compound has high potential as a drug candidate for the prevention and treatment of different cancers. The current review briefly reiterates the anti-cancer properties of PL against different types of cancer, which permits further investigation by conducting clinical studies. ER -